0 followers
EnBiotix is a late clinical-stage rare disease company currently focused on therapies for cystic fibrosis, non-CF bronchiectasis, and non-tuberculosis mycobacterial infections, a $15 billion global market.
Jeffrey Wager
Bristol-Myers Squibb
195 followers
Walgreens Boots Alliance
107 followers
Viatris
34 followers
Astellas Pharma
31 followers
Alnylam Pharmaceuticals
20 followers
Syneos Health
19 followers
Catalent
18 followers
NYU Langone Health
14 followers
Parexel
7 followers
West Pharmaceutical Services
7 followers
Nektar Therapeutics
7 followers
Explore companies